Evidence map›Paper›PMID 15057303›Full record

ArticleThe Journal of clinical investigation2004

Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.

Michael Nardi, Steven J Feinmark, Liang Hu, Zongdong Li, Simon Karpatkin

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Emerging Concepts in Immune Thrombocytopenia.Frontiers in immunology · 2018
    Review
  9. Article
  10. Review
  11. Article
  12. ADAMTS-18: a metalloproteinase with multiple functions.Frontiers in bioscience (Landmark edition) · 2014
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Michael NardiDepartment of Pediatrics, New York University School of Medicine, New York, New York 10016, USA.
Steven J Feinmark
Liang Hu
Zongdong Li
Simon Karpatkin
New York University · US

Funding

AIDS &THROMBOCYTOPENIA IN DRUG-ABUSERS &HOMOSEXUALSR01DA004315 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KARPATKIN, SIMON · 1986 to 2009
$3.5M
IMMUNOLOGY OF HUMAN PLATELETS (HIV-1-ITP)R01HL013336 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KARPATKIN, SIMON · 1985 to 2007
$2.5M
NHLBI NIH HHS HL-13336NHLBI NIH HHS R01 HL013336NIDA NIH HHS DA-04315NIDA NIH HHS R01 DA004315
6 · The paper itself

Abstract

Antiplatelet GPIIIa49-66 Ab of HIV-related thrombocytopenic patients induces thrombocytopenia and platelet fragmentation by the generation of peroxide and other reactive oxygen species (ROS). Here we report the presence of a functional platelet NADPH oxidase pathway that requires activation by the platelet 12-lipoxygenase (12-LO) pathway to fragment platelets. A new Ab-mediated mechanism is described in which the platelet 12-LO product, 12(S)-HETE activates the NADPH oxidase pathway to generate ROS.

Indexed as

AntibodiesArachidonate 12-LipoxygenaseBlood PlateletsComplement System ProteinsHIV-1HIV InfectionsHumansNADPNADPH OxidasesOxidation-ReductionReactive Oxygen SpeciesThrombocytopeniaAntibodiesArachidonate 12-LipoxygenaseComplement System ProteinsNADPNADPH OxidasesReactive Oxygen Species

Identifiers

PMID15057303
PMCPMC379327
OpenAlexW2083332835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.